RetractedArticleBioengineered2022

Clinical practice of epidermal growth factor receptor-tyrosine kinase inhibitor targeted drugs combined with gadolinium oxide nanoparticles in the treatment of non-small cell lung cancer.

Xuan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.